Related Experiment Video

Updated: Jun 21, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Respiratory syncytial virus bronchiolitis and asthma - insights from recent studies and implications for therapy

Beena Mailaparambil1, Ruth Grychtol, Andrea Heinzmann

  • 1Centre for Pediatrics and Adolescent Medicine, University of Freiburg, D-79106 Freiburg, Germany.

Inflammation & Allergy Drug Targets
|July 16, 2009
PubMed

Insights

Severe respiratory syncytial virus (RSV) infection in infants may be linked to childhood asthma development. Genetic studies explore common pathways and potential targeted therapies for both conditions.

Area of Science:

  • Pediatric respiratory infections
  • Immunogenetics
  • Asthma research

Background:

  • Respiratory syncytial virus (RSV) is a major cause of infant respiratory illness, leading to significant disease burden and hospitalizations.
  • The relationship between severe RSV bronchiolitis in infancy and the later development of asthma remains a critical area of research and debate.
  • A shared genetic predisposition for exaggerated inflammatory responses in the lungs could underlie both conditions.

Purpose of the Study:

  • To review current genetic findings in bronchial asthma and severe RSV bronchiolitis.
  • To discuss the potential causal link between infantile RSV bronchiolitis and childhood asthma, considering epidemiological evidence.
  • To explore the implications of genetic research for targeted drug therapies for both diseases.

Main Methods:

  • Literature review of genetic studies on asthma and RSV bronchiolitis.
  • Analysis of epidemiological data investigating the association between early RSV infection and later asthma diagnosis.
  • Synthesis of current understanding regarding common and distinct genetic pathways.

Main Results:

  • Genetic studies are crucial for elucidating shared and divergent mechanisms in asthma and RSV bronchiolitis.
  • Epidemiological evidence is being considered to assess the relationship between severe RSV bronchiolitis and childhood asthma.
  • Findings have the potential to reshape the understanding and therapeutic strategies for both conditions.

Conclusions:

  • Understanding the genetic underpinnings of RSV bronchiolitis and asthma may reveal common inflammatory pathways.
  • Further genetic research is essential to clarify the etiological relationship and inform therapeutic interventions.
  • This review highlights the importance of genetic insights for developing targeted treatments for pediatric respiratory diseases.

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...